english.prescrire.org > Spotlight > 100 most recent

Spotlight

Every month, the subjects in Prescrire’s Spotlight.

100 most recent :  1 | 10 | 20 | 30 | 40 | 50 | 60 | 70 | 80 | 90

  The 2021 "Prescrire Prize" is awarded
  to 4 books about health and healthcare

Bulevirtide (Hepcludex°) and chronic hepatitis D: no evidence of efficacy based on clinical endpoints

In the October issue of Prescrire International - Multidrug-resistant pulmonary tuberculosis and delamanid: no demonstrated clinical benefit

Covid-19 vaccines: glaring inequality

Oral tramadol: children still being exposed to the risk of overdose

Titanium dioxide: is it carcinogenic in humans?

Supplementary protection certificates: highly profitable for drug companies

The Sars-CoV-2 Delta variant: how effective are covid-19 vaccines against this strain?

Covid-19 : Follow Prescrire's independent, evidence-based analysis of the pandemic

Viral vector covid-19 vaccine ChAdOx1-S (Vaxzevria°) and covid-19. Efficacy in the short term, but a risk of rare, sometimes fatal, thrombosis

1 | 10 | 20 | 30 | 40 | 50 | 60 | 70 | 80 | 90